Curcumin, the active compound of turmeric (Curcuma longa L.), is responsible for various therapeutic properties of the plant, such as anticancer, antioxidant, anti-inflammatory, antibacterial, antiviral, antifungal, antiparasitic, wound-healing, and digestive activities, among others. In vitro studies have revealed that curcumin exhibits no toxicity against human red blood cells, highlighting its biological safety. A daily dose of up to 12g/day does not cause adverse effects in healthy individuals. However, despite good oral tolerance, its low bioavailability limits its applications, which can be overcome by incorporating curcumin powder (CCMP) into nanoformulations. Many studies have been reported with the aim of improving the bioavailability of CCMP using nanoformulations. However, there still need to be reports on using titanate nanotubes for this purpose. This work aimed to formulate a nanocomposite between sodium titanate nanotubes (NaTiNT) and CCMP. The NaTiNTs were synthesized using the alkaline hydrothermal method and subjected to heterojunction with CCMP, forming the NaTiNT@CCMP sample. The structural characterization of the material was carried out using XRD, FT-IR, TG, XPS, and TEM techniques, which confirmed the union and the intact physical integrity of both after the junction. The results obtained from thermogravimetric analysis demonstrated the thermal stability that CCMP acquired upon bonding with the titanate nanotubes. XPS detected the bond formed between CCMP and the titanium of NaTiNTs. The biological evaluation was conducted through in vitro assays of Residual Hemolytic Activity (%HR) and cytotoxicity assessment (MTT), which was performed with rat bone marrow mesenchymal stem cells (BMMSCs). The biological test results showed that the NaTiNT sample exhibited hemolytic activity at 50mgmL-1. In comparison, the CCMP sample showed reduced viability at 50mgmL-1 and 25mgmL-1 concentrations and slightly reduced viability at 6.25mgmL-1. The NaTiNT@CCMP sample, on the other hand, did not have hemolytic activity at any of the concentrations studied. In the cytotoxicity test, samples with varying concentrations of NaTiNT and CCMP demonstrated reduced overall viability over 48hours. However, in the meantime, the heterojunction of the two samples, at most concentrations used, exhibited viability similar to that of the control and did not show cytotoxicity to the cells studied. In summary, the heterojunction of the two structures leads to low hemolytic activity and minimal cytotoxicity compared to both isolated structures.
Read full abstract